Cancer drug resistance: an evolving paradigm

C Holohan, S Van Schaeybroeck, DB Longley… - Nature Reviews …, 2013 - nature.com
Resistance to chemotherapy and molecularly targeted therapies is a major problem facing
current cancer research. The mechanisms of resistance to'classical'cytotoxic …

Pharmacologic resistance in colorectal cancer: a review

WA Hammond, A Swaika… - Therapeutic advances in …, 2016 - journals.sagepub.com
Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in
both men and women worldwide. This is in spite of widespread, effective measures of …

Circadian rhythms, disease and chronotherapy

Y Lee, JM Field, A Sehgal - Journal of biological rhythms, 2021 - journals.sagepub.com
Circadian clocks are biological timing mechanisms that generate 24-h rhythms of physiology
and behavior, exemplified by cycles of sleep/wake, hormone release, and metabolism. The …

Standing the test of time: targeting thymidylate biosynthesis in cancer therapy

PM Wilson, PV Danenberg, PG Johnston… - Nature reviews Clinical …, 2014 - nature.com
Over the past 60 years, chemotherapeutic agents that target thymidylate biosynthesis and
the enzyme thymidylate synthase (TS) have remained among the most-successful drugs …

5-fluorouracil: mechanisms of action and clinical strategies

DB Longley, DP Harkin, PG Johnston - Nature reviews cancer, 2003 - nature.com
Fluorouracil (5-FU) is widely used in the treatment of cancer. Over the past 20 years,
increased understanding of the mechanism of action of 5-FU has led to the development of …

Gastric cancer

HH Hartgrink, EPM Jansen, NCT van Grieken… - The Lancet, 2009 - thelancet.com
Gastric cancer is the second most frequent cause of cancer death worldwide, although much
geographical variation in incidence exists. Prevention and personalised treatment are …

Molecular mechanisms of drug resistance

DB Longley, PG Johnston - The Journal of Pathology: A Journal …, 2005 - Wiley Online Library
Resistance to chemotherapy limits the effectiveness of anti‐cancer drug treatment. Tumours
may be intrinsically drug‐resistant or develop resistance to chemotherapy during treatment …

5-Fluorouracil: mechanisms of resistance and reversal strategies

N Zhang, Y Yin, SJ Xu, WS Chen - Molecules, 2008 - mdpi.com
The purpose of this work is to review the published studies on the mechanisms of action and
resistance of 5-fluorouracil. The review is divided into three main sections: mechanisms of …

[HTML][HTML] Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells

C Yang, J Song, S Hwang, J Choi, G Song, W Lim - Redox Biology, 2021 - Elsevier
Although effective drugs have been developed, including 5-fluorouracil (5-FU), advanced
colorectal cancer (CRC) shows low therapeutic sensitivity resulting from the development of …

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected …

Study Group of Surgical Adjuvant Therapy for … - Cancer, 2002 - Wiley Online Library
BACKGROUND To the authors' knowledge, the significance of postoperative adjuvant
chemotherapy in pancreaticobiliary carcinoma has not yet been clarified. A randomized …